Sharekhan

Rossari Biotech Ltd

Wed 30/04/2025,15:59:54 NSE: ROSSARI

₹ 658.05 -22.90 (-3.36%)
BUY NOW Buy Rossari Biotech Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Rossari Biotech Ltd

Wed 30/04/2025,16:1:0

Rossari Biotech Ltd

Wed 30/04/2025,15:59:54 | NSE : ROSSARI

₹ 658.05-22.90 (-3.36%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 671.30

Previous Close

₹ 680.95

Volume

93955

Mkt Cap ( Rs. Cr)

₹3643.40

High

₹ 690.00

Low

₹ 654.00

52 Week High

₹ 972.70

52 Week Low

₹ 569.00

Book Value Per Share

₹ 201.88

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Rossari Biotech Ltd

Your Vote -

Buy

28.44%

Hold

46.29%

Sell

25.26%

28.44%

661 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

658.05

136

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

136

Option Chain

Analyzes market sentiment, predicts Rossari Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    28 Apr 2025, 8:33PM Rossari Biotech Limited has informed the Exchange about Link of Recording

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    28 Apr 2025, 8:32PM Audio recording of Earnings Conference call for Q4 FY25.\r\n

  • Rossari Biotech - Copy of Newspaper Publication

    26 Apr 2025, 11:39PM Newspaper publication of extracts of Consolidated Annual Financial Results for the Quarter and Financial Year ended March 31, 2025.

  • Rossari Biotech - Press Release

    26 Apr 2025, 11:32PM Rossari Biotech Limited has informed the Exchange regarding a press release dated April 25, 2025, titled ""Rossari Biotech announces Q4 & FY25 results

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    26 Apr 2025, 11:32PM Rossari Biotech Limited has informed the Exchange regarding press release dated April 25, 2025 titled \Rossari Biotech announces Q4 & FY25 results\.

  • Rossari Biotech - Investor Presentation

    26 Apr 2025, 11:24PM Rossari Biotech Limited has informed the Exchange about Investor Presentation

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation

    26 Apr 2025, 11:24PM Intimation of Q4 FY 25 - Earnings Presentation.

  • Rossari Biotech - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    25 Apr 2025, 11:42PM ROSSARI BIOTECH LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Age

  • Rossari Biotech - Outcome of Board Meeting-XBRL

    25 Apr 2025, 11:39PM ROSSARI BIOTECH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 25-Apr-2025 for Dividend

  • Rossari Biotech - Alteration Of Capital and Fund Raising-XBRL

    25 Apr 2025, 11:36PM ROSSARI BIOTECH LIMITED has informed the Exchange regarding Allotment of Securities

  • Rossari Biotech - Capacity addition

    25 Apr 2025, 11:23PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    25 Apr 2025, 11:23PM Intimation of approval of capacity addition.

  • Rossari Biotech - Updates

    25 Apr 2025, 11:16PM Appointment of M/s. Shah Patel & Associates, Practicing Company Secretaries, as Secretarial Auditor of the Company.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    25 Apr 2025, 11:16PM Appointment of M/s. Shah Patel & Associates, Practicing Company Secretaries, as Secretarial Auditor of the Company.

  • Rossari Biotech - Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 2019

    25 Apr 2025, 10:53PM Intimation of grant of 834250 options under Rossari Employee Stock Option Plan -2019.

  • Rossari Biotech - ESOP/ESOS/ESPS

    25 Apr 2025, 10:52PM Intimation of Grant of 834250 Options under Rossari Employee Stock Option Plan- 2019

  • Rossari Biotech - ESOP/ESOS/ESPS

    25 Apr 2025, 10:44PM Intimation of Allotment of 2825 Equity shares under Rossari Employee Stock Option Plan-2019.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    25 Apr 2025, 10:40PM Intimation of allotment 2825 Equity shares under Rossari Employee Stock Option Plan -2019.

  • Rossari Biotech - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31,

    25 Apr 2025, 9:12PM Audited Financial Results(Standalone and Consolidated) for the quarter and financial year ended March 31, 2025.

  • Rossari Biotech - Corporate Action-Board approves Dividend

    25 Apr 2025, 8:56PM Board has recommended final dividend of 25% i.e Re. 0.50/- per share on Equity shares of the face value of Rs. 2/- each for the Financial Year ended M

  • Rossari Biotech - Dividend

    25 Apr 2025, 8:47PM Rossari Biotech Limited has informed the Exchange that Board of Directors at its meeting held on April 25, 2025, recommended Final Dividend of Rs. 0.5

  • Rossari Biotech Q4 net profit up 23.65% at Rs 32.36 cr

    25 Apr 2025, 8:40PM The company reported standalone net profit of Rs 32.36 crore for the quarter ended March 31, 2025 as compared to Rs 26.17 crore in the same period las

  • Rossari Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On April 25, 2025.

    25 Apr 2025, 8:39PM Outcome of Board Meeting held on April 25, 2025.

  • Rossari Biotech - Outcome of Board Meeting

    25 Apr 2025, 8:33PM Outcome of Board Meeting held on April 25, 2025.

  • Rossari Biotech - Capacity addition

    25 Apr 2025, 12:20AM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    25 Apr 2025, 12:20AM Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    22 Apr 2025, 10:32PM Intimation of Earnings Conference call for investors and analysts on Monday, April 28, 2025 at 05:00 PM IST.\r\n

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    22 Apr 2025, 10:31PM Intimation of Earnings Conference call for investors and analysts on Monday, April 28, 2025 at 05:00 PM IST.

  • Rossari Biotech - Disclosure under SEBI Takeover Regulations

    22 Apr 2025, 4:59PM Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqui

  • Rossari Biotech - Intimation Of Change Of Communications Details Of Registrar And Share Transfer Agent

    18 Apr 2025, 8:13PM Rossari Biotech Limited has informed the Exchange regarding intimation of change of communications details of MUFG Intime India Private Limited (Regi

  • Rossari Biotech - Updates

    18 Apr 2025, 8:12PM Rossari Biotech Limited has informed the Exchange regarding intimation of change of communications details of MUFG Intime India Private Limited (Regis

  • Rossari Biotech - Board Meeting Intimation

    17 Apr 2025, 10:43PM ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 25-Apr-2025 to consider and approve the Yearly Audited Financial r

  • Rossari Biotech - Board Meeting Intimation for Board Meeting Intimation For Audited Financial Statements And Financial Result

    17 Apr 2025, 10:39PM Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 ,inter alia, to consider and

  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    11 Apr 2025, 6:50PM As of March 2025, 68.18% is owned by Indian Promoters and 31.82% by Public. <p align=justify> Institutional holds 21.57% (Insurance Companies 4.04%) a

  • Rossari Biotech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Apr 2025, 7:10PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.

  • Rossari Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Apr 2025, 7:09PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended March 31, 2025.

  • Rossari Biotech - Trading Window-XBRL

    26 Mar 2025, 8:53PM Rossari Biotech Limited has informed the Exchange about Closure of Trading Window

  • Rossari Biotech - Trading Window

    26 Mar 2025, 8:50PM Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Rossari Biotech - Action(s) taken or orders passed

    20 Feb 2025, 11:27AM Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Action(s) taken or orders passed

    6 Feb 2025, 3:37PM Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order

    6 Feb 2025, 3:36PM Intimation of Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Feb 2025, 8:39PM Intimation of Analyst/Institutional Investor Meet/Con. Call/Updates.

  • Rossari Biotech

    20 Oct 2022 , 10:21AM RBL has approved the incorporation of a wholly owned subsidiary in Bangladesh with an estimate aggregate Capital outlay of BDT 300 million (approximately Rs. 25 Crore). The Wholly Owned Subsidiary will enable the Company to expand the market for RBL products in Bangladesh. Positive for the stock

  • Rossari Biotech

    19 Jul 2021 , 10:22AM Rossari Biotech Limited (Rossari): The company has approved the acquisition of Tristar Intermediates Pvt. Ltd. As per the agreement, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates. 76% of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next 3 years. The total enterprise value of the transaction is Rs. 120 crores. Rossari plans to fund the investment through cash on balance sheet and doesn’t intend to raise any debt for this acquisition. The transaction will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term. The synergistic acquisition provides Rossari with enhanced portfolio of products, stronger presence in new & untapped international markets and access to newer technologies.

  • Rossari Biotech debuts at 58% premium

    23 Jul 2020 , 10:46AM Rossari Biotech lists at Rs. 670/Sh against the issue price of Rs. 425/Sh
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Rossari Biotech Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1107.318 1015.386 923.612 784.524 404.444
Liabilities 1107.318 1015.386 923.612 784.524 404.444
Equity 11.073 11.049 11.031 11.011 10.386
Gross Profit 186.235 161.254 122.648 122.793 120.855
Net Profit 114.742 99.645 71.39 79.474 79.102
Cash From Operating Activities 92.198 73.918 113.66 33.116 52.093
NPM(%) 8.01 8.28 7.32 7.4 11.45
Revenue 1431.628 1202.91 975.172 1072.844 690.414
Expenses 1245.393 1041.656 852.524 950.051 569.559
ROE(%) 10.26 8.91 6.38 7.11 7.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.5 25 0 699.35
16 Aug 2024 0.5 25 0 780.3
24 May 2023 0.5 25 0 695.5
07 Jul 2022 0.5 25 0 888.75
08 Sep 2021 0.5 25 0 1282.15

Peers

Other companies within the same industry or sector that are comparable to Rossari Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 54.00 -2.96 7.37 785.69 90.02 0.00
Shreeoswal Seeds and Chemicals Ltd 14.13 -1.26 0.00 6034.28 -22.75 0.00
GRM Overseas Ltd 315.70 -1.64 30.59 3958.20 498.18 0.00
Jain Irrigation Systems Ltd 52.50 -1.50 0.00 45305.56 33.67 0.00

Company Info

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 20212023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company 

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 20212023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company 

Read More

Parent Organisation

Rossari Biotech Ltd.

Founded

10/08/2009

Managing Director

Mr.Sunil Chari

NSE Symbol

ROSSARIEQ

FAQ

The current price of Rossari Biotech Ltd is ₹ 658.05.

The 52-week high for Rossari Biotech Ltd is ₹ 690.00 and the 52-week low is ₹ 654.00.

The market capitalization of Rossari Biotech Ltd is currently ₹ 3643.40. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Rossari Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Rossari Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Rossari Biotech Ltd shares.

The CEO of Rossari Biotech Ltd is Mr.Sunil Chari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT